Characterization	O
of	O
the	O
human	B-DNA
CD4	I-DNA
gene	I-DNA
promoter	I-DNA
:	O
transcription	O
from	O
the	O
CD4	B-DNA
gene	I-DNA
core	I-DNA
promoter	I-DNA
is	O
tissue-specific	O
and	O
is	O
activated	O
by	O
Ets	B-protein
proteins	I-protein
.	O

We	O
analyzed	O
the	O
5	B-DNA
'	I-DNA
transcription	I-DNA
control	I-DNA
sequences	I-DNA
of	O
the	O
human	B-DNA
CD4	I-DNA
gene	I-DNA
.	O

We	O
located	O
the	O
transcription	B-DNA
initiation	I-DNA
site	I-DNA
and	O
showed	O
that	O
the	O
CD4	B-DNA
core	I-DNA
promoter	I-DNA
(	O
positions	B-DNA
-40	I-DNA
to	I-DNA
+16	I-DNA
)	O
lacks	O
a	O
classical	O
``	O
TATA	O
''	O
or	O
initiator	B-DNA
positioning	I-DNA
consensus	I-DNA
sequence	I-DNA
but	O
directs	O
precise	O
and	O
efficient	O
transcription	O
when	O
coupled	O
to	O
the	O
ubiquitously	O
active	O
simian	B-DNA
virus	I-DNA
40	I-DNA
enhancer	I-DNA
.	O

The	O
transcriptional	O
activity	O
of	O
the	O
CD4	B-DNA
gene	I-DNA
promoter	I-DNA
correlated	O
with	O
CD4	O
expression	O
in	O
various	O
cell	O
types	O
.	O

Interestingly	O
,	O
the	O
CD4	B-DNA
core	I-DNA
promoter	I-DNA
also	O
displayed	O
a	O
tissue-specific	O
transcriptional	O
activity	O
.	O

Within	O
this	O
fragment	O
,	O
three	O
nucleic	O
acid	O
sequences	O
are	O
completely	O
conserved	O
in	O
the	O
murine	B-DNA
CD4	I-DNA
gene	I-DNA
.	O

One	O
of	O
these	O
sequences	O
contains	O
a	O
perfect	B-DNA
ETS	I-DNA
consensus	I-DNA
sequence	I-DNA
.	O

Another	O
ETS	B-DNA
consensus	I-DNA
sequence	I-DNA
is	O
located	O
1060	O
nt	O
upstream	O
.	O

Electrophoretic-mobility-shift	O
assays	O
showed	O
that	O
the	O
core	O
promoter	O
ETS	O
motif	O
binds	O
an	O
Ets-related	B-protein
protein	I-protein
specifically	O
expressed	O
at	O
high	O
levels	O
in	O
CD4+	B-cell_type
cells	I-cell_type
.	O

Moreover	O
,	O
in	O
CD4-	B-cell_type
cells	I-cell_type
,	O
overexpression	O
of	O
Ets-1	B-protein
or	O
Ets-2	B-protein
efficiently	O
and	O
specifically	O
activated	O
transcription	O
from	O
the	O
CD4	B-DNA
promoter	I-DNA
and	O
core	B-DNA
promoter	I-DNA
.	O

These	O
data	O
indicate	O
that	O
Ets	B-protein
transcription	I-protein
factors	I-protein
play	O
a	O
central	O
role	O
in	O
controlling	O
CD4	O
gene	O
expression	O
,	O
by	O
binding	O
to	O
both	O
a	O
classical	B-DNA
remote	I-DNA
site	I-DNA
and	O
an	O
unusual	O
proximal	B-DNA
activator	I-DNA
sequence	I-DNA

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

90	NULL
,	NULL
pp	NULL
.	NULL

7739-7743	NULL
,	NULL
August	NULL
1993	NULL
Biochemistry	NULL
Characterization	NULL
of	NULL
the	NULL
human	NULL
CD4	NULL
gene	NULL
promoter	NULL
:	NULL
Transcription	NULL
from	NULL
the	NULL
CD4	NULL
gene	NULL
core	NULL
promoter	NULL
is	NULL
tissue-specific	NULL
and	NULL
is	NULL
activated	NULL
by	NULL
Ets	NULL
proteins	NULL
PATRICK	NULL
SALMON*	NULL
,	NULL
AntoInE	NULL
Glovane	NULL
?	NULL

t	NULL
,	NULL
Bonpan	NULL
WasYLyk	NULL
?	NULL

,	NULL
anp	NULL
David	NULL
Kratzmann*t	NULL
*Laboratoire	NULL
de	NULL
Biologie	NULL
et	NULL
Génétique	NULL
des	NULL
Pathologies	NULL
Immunitaires	NULL
,	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
,	NULL
Unité	NULL
Recherche	NULL
Associée	NULL
1463	NULL
,	NULL
Hopital	NULL
de	NULL
la	NULL
Piti¢-Salpétrigre	NULL
,	NULL
83	NULL
Boulevard	NULL
de	NULL
l	NULL
'	NULL
Hopital	NULL
,	NULL
75651	NULL
Paris	NULL
Cedex	NULL
13	NULL
,	NULL
France	NULL
;	NULL
and	NULL
*Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique-Laboratorie	NULL
de	NULL
Génétique	NULL
Moleculaire	NULL
des	NULL
Eucaryotes/Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
Unité	NULL
184	NULL
,	NULL
Institut	NULL
de	NULL
Chimie	NULL
Biologique	NULL
,	NULL
Faculté	NULL
de	NULL
Médecine	NULL
,	NULL
67085	NULL
Strasbourg	NULL
,	NULL
France	NULL
Communicated	NULL
by	NULL
Jean-Pierre	NULL
Changeux	NULL
,	NULL
April	NULL
9	NULL
,	NULL
1993	NULL
(	NULL
received	NULL
for	NULL
review	NULL
December	NULL
24	NULL
,	NULL
1992	NULL
)	NULL
ABSTRACT	NULL
We	NULL
analyzed	NULL
the	NULL
5	NULL
transcription	NULL
control	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
CD4	NULL
gene	NULL
.	NULL

We	NULL
located	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
and	NULL
showed	NULL
that	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
(	NULL
positions	NULL
-40	NULL
to	NULL
+16	NULL
)	NULL
lacks	NULL
a	NULL
classical	NULL
``	NULL
TATA	NULL
``	NULL
or	NULL
initiator	NULL
positioning	NULL
consensus	NULL
sequence	NULL
but	NULL
directs	NULL
precise	NULL
and	NULL
efficient	NULL
transcription	NULL
when	NULL
coupled	NULL
to	NULL
the	NULL
ubiquitously	NULL
active	NULL
simian	NULL
virus	NULL
40	NULL
enhancer	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
promoter	NULL
correlated	NULL
with	NULL
CD4	NULL
expression	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
also	NULL
displayed	NULL
a	NULL
tissue-specific	NULL
transcriptional	NULL
activity	NULL
.	NULL

Within	NULL
this	NULL
fragment	NULL
,	NULL
three	NULL
nucleic	NULL
acid	NULL
sequences	NULL
are	NULL
completely	NULL
conserved	NULL
in	NULL
the	NULL
murine	NULL
CD4	NULL
gene	NULL
.	NULL

One	NULL
of	NULL
these	NULL
sequences	NULL
contains	NULL
a	NULL
perfect	NULL
ETS	NULL
consensus	NULL
sequence	NULL
.	NULL

Another	NULL
ETS	NULL
consensus	NULL
sequence	NULL
is	NULL
located	NULL
1060	NULL
nt	NULL
upstream	NULL
.	NULL

Electrophoretic-mobility-shift	NULL
assays	NULL
showed	NULL
that	NULL
the	NULL
core	NULL
promoter	NULL
ETS	NULL
motif	NULL
binds	NULL
an	NULL
Ets-related	NULL
protein	NULL
specifically	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
CD4+*	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
CD4~	NULL
cells	NULL
,	NULL
overexpression	NULL
of	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
efficiently	NULL
and	NULL
specifically	NULL
activated	NULL
transcription	NULL
from	NULL
the	NULL
CD4	NULL
promoter	NULL
and	NULL
core	NULL
promoter	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
Ets	NULL
transcription	NULL
factors	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
controlling	NULL
CD4	NULL
gene	NULL
expression	NULL
,	NULL
by	NULL
binding	NULL
to	NULL
both	NULL
a	NULL
classical	NULL
remote	NULL
site	NULL
and	NULL
an	NULL
unusual	NULL
proximal	NULL
activator	NULL
sequence	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
,	NULL
and	NULL
the	NULL
CD4	NULL
and	NULL
CD8	NULL
coreceptor	NULL
molecules	NULL
,	NULL
is	NULL
tightly	NULL
regulated	NULL
during	NULL
T-lymphocyte	NULL
differentiation	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Early	NULL
thymocytes	NULL
express	NULL
a	NULL
low	NULL
level	NULL
of	NULL
CD4	NULL
and	NULL
no	NULL
CD8	NULL
and	NULL
have	NULL
not	NULL
yet	NULL
rearranged	NULL
their	NULL
genes	NULL
coding	NULL
for	NULL
the	NULL
TCR	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
ref	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Later	NULL
,	NULL
they	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
both	NULL
CD4	NULL
and	NULL
CD8	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
rearranged	NULL
TCR	NULL
.	NULL

At	NULL
this	NULL
stage	NULL
,	NULL
most	NULL
of	NULL
the	NULL
thymocytes	NULL
undergo	NULL
apoptosis	NULL
,	NULL
presumably	NULL
because	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
an	NULL
inappropriate	NULL
set	NULL
of	NULL
receptor/coreceptor	NULL
molecules	NULL
.	NULL

The	NULL
surviving	NULL
thymocytes	NULL
continue	NULL
differentia-tion	NULL
,	NULL
losing	NULL
the	NULL
expression	NULL
of	NULL
either	NULL
CD4	NULL
or	NULL
CD8	NULL
,	NULL
depending	NULL
on	NULL
whether	NULL
their	NULL
TCR	NULL
is	NULL
specific	NULL
for	NULL
antigen	NULL
presented	NULL
in	NULL
the	NULL
context	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
or	NULL
II	NULL
molecules	NULL
,	NULL
respectively	NULL
.	NULL

Experiments	NULL
with	NULL
transgenic	NULL
mice	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
,	NULL
suggest	NULL
that	NULL
the	NULL
switch	NULL
from	NULL
CD4+*/CD8*+-double-positive	NULL
thymocytes	NULL
to	NULL
single-positive	NULL
lymphocytes	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
an	NULL
instructive	NULL
rather	NULL
than	NULL
a	NULL
stochastic	NULL
process	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
CD4	NULL
and	NULL
CD8	NULL
molecules	NULL
should	NULL
control	NULL
their	NULL
mutual	NULL
expression	NULL
during	NULL
the	NULL
thymocyte	NULL
maturation	NULL
process	NULL
.	NULL

Since	NULL
the	NULL
expression	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
molecules	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
,	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
CD4	NULL
and	NULL
CD8	NULL
genes	NULL
transcription	NULL
control	NULL
elements	NULL
is	NULL
essential	NULL
to	NULL
understand	NULL
the	NULL
complex	NULL
regulation	NULL
of	NULL
their	NULL
expression	NULL
.	NULL

We	NULL
mapped	NULL
the	NULL
human	NULL
CD4	NULL
gene	NULL
transcription	NULL
start	NULL
site	NULL
and	NULL
showed	NULL
that	NULL
the	NULL
surrounding	NULL
core	NULL
promoter	NULL
(	NULL
positions	NULL
-40	NULL
to	NULL
+16	NULL
)	NULL
is	NULL
sufficient	NULL
for	NULL
precise	NULL
initiation	NULL
of	NULL
transcription	NULL
,	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

7739	NULL
despite	NULL
the	NULL
absence	NULL
of	NULL
``	NULL
TATA	NULL
``	NULL
or	NULL
initiator	NULL
sequences	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

The	NULL
CD4	NULL
promoter	NULL
is	NULL
specifically	NULL
active	NULL
in	NULL
CD4*	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
alone	NULL
also	NULL
displays	NULL
a	NULL
significant	NULL
tissue-specific	NULL
activity	NULL
.	NULL

The	NULL
CD4	NULL
promoter	NULL
contains	NULL
two	NULL
sequences	NULL
capable	NULL
of	NULL
binding	NULL
Ets	NULL
proteins	NULL
,	NULL
one	NULL
located	NULL
1060	NULL
bp	NULL
upstream	NULL
from	NULL
the	NULL
start	NULL
site	NULL
and	NULL
the	NULL
second	NULL
within	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

Ets	NULL
proteins	NULL
form	NULL
a	NULL
distinct	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
ref	NULL
.	NULL

8	NULL
)	NULL
,	NULL
two	NULL
of	NULL
which	NULL
(	NULL
Ets-1	NULL
and	NULL
Elf-1	NULL
)	NULL
bind	NULL
regulatory	NULL
sequences	NULL
of	NULL
T-cell-specific	NULL
genes	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

We	NULL
show	NULL
that	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
binds	NULL
Ets-like	NULL
proteins	NULL
specifically	NULL
expressed	NULL
at	NULL
high	NULL
amounts	NULL
in	NULL
CD4	NULL
*	NULL
cells	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
overexpression	NULL
of	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
in	NULL
CD4~	NULL
HeLa	NULL
cells	NULL
efficiently	NULL
and	NULL
specifically	NULL
activates	NULL
the	NULL
CD4	NULL
promoter	NULL
and	NULL
core	NULL
promoter	NULL
.	NULL

Since	NULL
T	NULL
cells	NULL
express	NULL
multiple	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
(	NULL
10-14	NULL
)	NULL
and	NULL
since	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
are	NULL
specifically	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
CD4*	NULL
thymocytes	NULL
and	NULL
lymphocytes	NULL
(	NULL
11	NULL
)	NULL
,	NULL
we	NULL
thus	NULL
propose	NULL
that	NULL
Ets	NULL
proteins	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
tissue	NULL
specificity	NULL
of	NULL
CD4	NULL
gene	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Phage	NULL
,	NULL
Plasmids	NULL
,	NULL
and	NULL
Oligonucleotides	NULL
.	NULL

The	NULL
two	NULL
distal	NULL
EcoRI-HindIII	NULL
fragments	NULL
of	NULL
phage	NULL
AMP	NULL
(	NULL
24	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
pGEM-3Z	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
sequenced	NULL
,	NULL
and	NULL
aligned	NULL
with	NULL
cDNA	NULL
5	NULL
'	NULL
sequence	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Expression	NULL
plasmids	NULL
as	NULL
follows	NULL
were	NULL
derived	NULL
from	NULL
pCAT	NULL
vectors	NULL
(	NULL
Promega	NULL
)	NULL
:	NULL
CAT-Control	NULL
,	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
promoter	NULL
plus	NULL
enhancer	NULL
(	NULL
named	NULL
here	NULL
SV40	NULL
)	NULL
;	NULL
CAT-Enhancer	NULL
,	NULL
SV40	NULL
enhancer	NULL
alone	NULL
;	NULL
CAT-Basic	NULL
,	NULL
no	NULL
transcription	NULL
sequences	NULL
.	NULL

All	NULL
subclonings	NULL
were	NULL
performed	NULL
using	NULL
classical	NULL
methods	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
CD4	NULL
Pst	NULL
I	NULL
fragment	NULL
from	NULL
positions	NULL
-1076	NULL
to	NULL
+20	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
was	NULL
cloned	NULL
in	NULL
the	NULL
CAT-Basic	NULL
,	NULL
generating	NULL
proT4	NULL
.	NULL

The	NULL
CD4	NULL
core	NULL
promoter	NULL
,	NULL
a	NULL
CD4	NULL
synthetic	NULL
double-strand	NULL
oligonucleotide	NULL
from	NULL
positions	NULL
-40	NULL
to	NULL
+16	NULL
with	NULL
HindIII	NULL
and	NULL
Xba	NULL
I	NULL
adapters	NULL
(	NULL
named	NULL
CD4	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
,	NULL
was	NULL
cloned	NULL
in	NULL
both	NULL
CAT-Basic	NULL
and	NULL
CAT-Enhancer	NULL
,	NULL
generating	NULL
pT4	NULL
and	NULL
pT4+eSV	NULL
,	NULL
respectively	NULL
.	NULL

Basic	NULL
,	NULL
proT4	NULL
,	NULL
pT4	NULL
,	NULL
and	NULL
pT4+eSV	NULL
cassettes	NULL
were	NULL
tested	NULL
both	NULL
in	NULL
their	NULL
original	NULL
pUC19	NULL
(	NULL
pCAT	NULL
vectors	NULL
)	NULL
and	NULL
in	NULL
the	NULL
Bluescript	NULL
SK	NULL
*	NULL
(	NULL
Stratagene	NULL
)	NULL
parental	NULL
vectors	NULL
,	NULL
to	NULL
test	NULL
for	NULL
the	NULL
influence	NULL
of	NULL
plasmidic	NULL
sequences	NULL
.	NULL

For	NULL
each	NULL
construct	NULL
,	NULL
independent	NULL
preparations	NULL
of	NULL
independent	NULL
clones	NULL
were	NULL
prepared	NULL
for	NULL
functional	NULL
assays	NULL
.	NULL

All	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
using	NULL
the	NULL
Gene	NULL
Assembler	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

All	NULL
but	NULL
sequencing	NULL
primers	NULL
were	NULL
purified	NULL
in	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
as	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Primer-Extension	NULL
and	NULL
Mung	NULL
Bean	NULL
Nuclease	NULL
Analyses	NULL
.	NULL

Total	NULL
RNAs	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
guanidine	NULL
isothiocyanate/	NULL
cesium	NULL
chloride	NULL
method	NULL
and	NULL
were	NULL
subjected	NULL
to	NULL
primer	NULL
exten-	NULL
Abbreviations	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
RPC	NULL
,	NULL
RNA	NULL
polymerase	NULL
II	NULL
initiation	NULL
complex	NULL
;	NULL
CB	NULL
,	NULL
conserved	NULL
box	NULL
;	NULL
SV40	NULL
,	NULL
simian	NULL
virus	NULL
40	NULL
;	NULL
TCR	NULL
,	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
.	NULL

*To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

7740	NULL
Biochemistry	NULL
:	NULL
Salmon	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
A	NULL
5	NULL
ioTecAagocTicAAloT|TcoTG	NULL
@	NULL
ecTCaAAGCAATCCTCCCACCTCGGCCTCCTAAAATACTGGGATTATAGGCATGAGCCACCACTCCCAGCACCACTTT	NULL
-980	NULL
Poti	NULL
MYB	NULL
-	NULL
ETS	NULL
TTTCAGACTGGAAAAGAACACTCACATGTGCATCTTTAAATGACACTTGGGCTGTGGTATGGAGAATGGCCACCAGTGAGTAGGCAGGAGCTGTTGToce	NULL
-880	NULL
AGCAAGGGCTGATATTGGCATCTTGGATTGGCATGGTGGCAGTAGTGGTAGTGCAGAGTGACTTGGGTAGATTTTGGAGCATTTAGAAGGTACATCCACA	NULL
-780	NULL
GGAACTGGTAAATAAATACGTGGGAGAAGTTGGGTGAAGGGGGTGTCAAAGATTACACCCAATTTATTTTGCTTGGGAAGTTGeTecaATG	NULL
@	NULL
TGAGCCOcT	NULL
-680	NULL
MYB	NULL
MYB	NULL
MYB	NULL
CACTGAGTGAGAAGCCTGGAGAAGCAGGTTTGGAGGGTGGTAGTATGCAGG	NULL
@	NULL
TG	NULL
@	NULL
TATGCATAGTTGecaATGTGeT	NULL
@	NULL
TTG	NULL
@	NULL
AGTTTGCTATGTCCG	NULL
@	NULL
@	NULL
TG	NULL
@	NULL
AGcT	NULL
-580	NULL
TCCCAGTGGAGATGTCCAATGGGCAGACGGATACTCACATAGAGAGTTCATGGTAGATTCGGGCTAGAGGAAAGCACCTGAGGCCTGGCCAGAGACG	NULL
@	NULL
CCT	NULL
-480	NULL
AGAGGAACAGAGCCTGGTTAACAGTCACTCCTGGTGTCTCAGATATTCTCTGCTCAGCCCACGCCCTCTCTTCCACACTGGGCCACCTATAAAGCCTCCA	NULL
-380	NULL
M	NULL
MYB	NULL
CAGATACCCCTGGGGCACCCACTGGACACAATTGCCCTCAGGGCCCCAGAGCAAGGAGCTGTTTGTGG	NULL
@	NULL
@	NULL
CTTACCACTGCTGTTCCCATATGCCCGGAAG	NULL
-280	NULL
ﬂGCCTCCCACTTCTTTCCCCACAGCOTGGTCAGACATGGCACTACCACTAATGGAATCTTTCTTGCCATCTTTTTCTTGCCGTTTAACAGTGGOAGTGAC	NULL
-	NULL
1	NULL
8	NULL
0	NULL
ACTTGACTCCTGATTAAGCCTGATTCTGClTAACﬂTTTTCCCTTGACTTTGGCATTTTCACTT7GACATGTTCCCTGAGAGCCTGGGGGGTGGGGAACCA	NULL
-	NULL
8	NULL
0	NULL
ETS	NULL
Hinf1	NULL
Pstl	NULL
+1	NULL
GCTCCAGCTG	NULL
@	NULL
TGACG	NULL
@	NULL
GTTTGG	NULL
@	NULL
G	NULL
@	NULL
@	NULL
CCc	NULL
@	NULL
e	NULL
@	NULL
cccac	NULL
@	NULL
ccTtaceetT	NULL
@	NULL
eTecacca	NULL
@	NULL
coTTteccatcas	NULL
etctectetTtcattTAaccacéACTCTECAGA	NULL
+2	NULL
AGGAACAAAGCACCCTCCCCACTGGG	NULL
@	NULL
CTCCTG	NULL
@	NULL
TTGCAGAGCTCGCAAGTCCTCACACAGATACG	NULL
@	NULL
CCTG	NULL
@	NULL
TTTGaGAaaG	NULL
@	NULL
casc	NULL
@	NULL
ec	NULL
@	NULL
caacaaacacG	NULL
@	NULL
Gaacc	NULL
+121	NULL
ETS	NULL
Saci	NULL
MYB	NULL
CACAGCTCTG	NULL
@	NULL
CCACCTTCTOTTGCATTTOTCTTrGGAACT	NULL
@	NULL
GGTCOATGAGCAGCOGATTTCOCACTG	NULL
@	NULL
acaAcToTeaccrtcoacaA	NULL
@	NULL
oTAcacaAcTorectAaca	NULL
cr..	NULL
0.3kb	NULL
__	NULL
+170	NULL
CCTGCCTCCCTCGGCAAGGCCACAATGAACCGG	NULL
@	NULL
G	NULL
@	NULL
eAGTC	NULL
3	NULL
Met	NULL
Aan	NULL
Arg	NULL
Hin	NULL
-	NULL
1	NULL
6	NULL
0	NULL
-	NULL
150	NULL
-	NULL
1	NULL
4	NULL
0	NULL
-	NULL
1	NULL
30	NULL
-	NULL
11	NULL
0	NULL
-	NULL
1	NULL
0	NULL
0	NULL
-	NULL
9	NULL
0	NULL
-	NULL
8	NULL
0	NULL
Human	NULL
tareochearrcrec	NULL
Mouse	NULL
CCAGC	NULL
GATTOTGOTCAGGCATTT	NULL
TCA	NULL
GLGACTTTGGCATT	NULL
-	NULL
70	NULL
-	NULL
6	NULL
0	NULL
-	NULL
5	NULL
0	NULL
-	NULL
4	NULL
-	NULL
3	NULL
0	NULL
TITAATTTITTCAACTTICCCCAACAACTegc	NULL
@	NULL
@	NULL
tGecagacacceeacreo	NULL
-	NULL
1	NULL
0	NULL
v	NULL
v¥v	NULL
v	NULL
+10	NULL
+2	NULL
0	NULL
0	NULL
-	NULL
20	NULL
AGCTGGTGACGTTTGGGGCCGGGCCAGBCCTAGGGTGTecAGGAGCCTTGﬁCﬁTC	NULL
GGC	NULL
T	NULL
TCCTGTC	NULL
TCT	NULL
OT-TCATTT-AAGCACGACTCTEGCAGAAGG	NULL
--	NULL
--	NULL
--	NULL
TGA	NULL
--	NULL
--	NULL
--	NULL
G	NULL
@	NULL
GGCTGGCTTACGTCCGCCG	NULL
@	NULL
TGCAGAGGAGCCTICACGACCAGGCTTGCTGTCIT	NULL
--	NULL
|LTCATTTACGAACA	NULL
TGIGTGAAGGCAA	NULL
ETS	NULL
A	NULL
A	NULL
A	NULL
L	NULL
La	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Human	NULL
CD4	NULL
gene	NULL
5	NULL
'	NULL
region	NULL
and	NULL
sequence	NULL
homologies	NULL
between	NULL
human	NULL
and	NULL
mouse	NULL
CD4	NULL
proximal	NULL
promoter	NULL
regions	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Sequence	NULL
of	NULL
the	NULL
human	NULL
CD4	NULL
gene	NULL
5	NULL
'	NULL
region	NULL
.	NULL

Position	NULL
+1	NULL
corresponds	NULL
to	NULL
the	NULL
major	NULL
start	NULL
site	NULL
identified	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Restriction	NULL
sites	NULL
for	NULL
Pst	NULL
I	NULL
,	NULL
Sac	NULL
I	NULL
,	NULL
and	NULL
Hinfl	NULL
are	NULL
indicated	NULL
.	NULL

Sequences	NULL
homologous	NULL
to	NULL
ETS	NULL
and	NULL
MYB	NULL
consensus	NULL
sequences	NULL
are	NULL
boxed	NULL
.	NULL

The	NULL
first	NULL
intron	NULL
,	NULL
between	NULL
mRNA	NULL
nt	NULL
+127	NULL
and	NULL
+128	NULL
(	NULL
9.6	NULL
kb	NULL
)	NULL
is	NULL
shaded	NULL
.	NULL

The	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
CD4	NULL
cDNA1	NULL
(	NULL
nt	NULL
+5	NULL
)	NULL
and	NULL
CD4	NULL
cDNA2	NULL
(	NULL
nt	NULL
+117	NULL
)	NULL
are	NULL
boxed	NULL
.	NULL

The	NULL
corresponding	NULL
5°	NULL
end	NULL
of	NULL
the	NULL
murine	NULL
CD4	NULL
promoter	NULL
(	NULL
16	NULL
)	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
M	NULL
below	NULL
nt	NULL
-422	NULL
.	NULL

The	NULL
first	NULL
three	NULL
codons	NULL
of	NULL
the	NULL
CD4	NULL
protein	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sequence	NULL
alignment	NULL
of	NULL
human	NULL
and	NULL
mouse	NULL
CD4	NULL
proximal	NULL
promoter	NULL
regions	NULL
.	NULL

Human	NULL
CD4	NULL
sequence	NULL
(	NULL
nt	NULL
~163	NULL
to	NULL
+24	NULL
)	NULL
was	NULL
aligned	NULL
with	NULL
the	NULL
corresponding	NULL
mouse	NULL
sequence	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

v	NULL
,	NULL
Start	NULL
sites	NULL
of	NULL
human	NULL
CD4	NULL
mRNAs	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
;	NULL
*	NULL
,	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
two	NULL
murine	NULL
CD4	NULL
cDNAs	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
;	NULL
a	NULL
,	NULL
start	NULL
sites	NULL
of	NULL
the	NULL
mouse	NULL
CD4	NULL
gene	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Nucleotide	NULL
homologies	NULL
are	NULL
shaded	NULL
and	NULL
CBs	NULL
are	NULL
outlined	NULL
.	NULL

The	NULL
nucleotides	NULL
of	NULL
the	NULL
ETS	NULL
consensus	NULL
core	NULL
are	NULL
indicated	NULL
in	NULL
boldface	NULL
type	NULL
.	NULL

sion	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

For	NULL
each	NULL
primer	NULL
extension	NULL
,	NULL
a	NULL
plasmid	NULL
containing	NULL
a	NULL
sequence	NULL
overlapping	NULL
the	NULL
expected	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
RNAs	NULL
was	NULL
sequenced	NULL
using	NULL
the	NULL
same	NULL
5'-end-*P-labeled	NULL
oligonucleotide	NULL
that	NULL
was	NULL
used	NULL
for	NULL
primer	NULL
extension	NULL
.	NULL

Sequencing	NULL
reaction	NULL
products	NULL
were	NULL
electrophoresed	NULL
alongside	NULL
the	NULL
primer-extension	NULL
products	NULL
.	NULL

Mung	NULL
bean	NULL
nuclease	NULL
protections	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Conditions	NULL
used	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
are	NULL
280	NULL
mM	NULL
NaCl	NULL
and	NULL
100	NULL
units	NULL
of	NULL
mung	NULL
bean	NULL
nuclease	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
S'-end-P-labeled	NULL
oligonucleotides	NULL
were	NULL
used	NULL
as	NULL
size	NULL
markers	NULL
.	NULL

Cells	NULL
and	NULL
Transfections	NULL
.	NULL

Cells	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
Jurkat	NULL
(	NULL
CD4+*	NULL
mature	NULL
T	NULL
cell	NULL
)	NULL
,	NULL
CEM	NULL
(	NULL
CD4+/CD8+*	NULL
immature	NULL
T	NULL
cell	NULL
)	NULL
,	NULL
RPMI	NULL
(	NULL
CD4~	NULL
pre	NULL
T	NULL
cell	NULL
)	NULL
,	NULL
U937	NULL
(	NULL
CD4+	NULL
monocytic	NULL
cell	NULL
)	NULL
,	NULL
HeLa	NULL
(	NULL
CD4~	NULL
epithelial	NULL
cell	NULL
)	NULL
,	NULL
HepG2	NULL
(	NULL
CD4~-	NULL
hepatocytic	NULL
cell	NULL
)	NULL
,	NULL
and	NULL
U373	NULL
(	NULL
CD4~	NULL
astrocytic	NULL
cell	NULL
,	NULL
named	NULL
here	NULL
``	NULL
Astro	NULL
``	NULL
to	NULL
avoid	NULL
confusion	NULL
with	NULL
U937	NULL
cells	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
electrotransfected	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
ref	NULL
.	NULL

20	NULL
and	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Determination	NULL
of	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
activity	NULL
was	NULL
performed	NULL
48	NULL
h	NULL
later	NULL
as	NULL
described	NULL
(	NULL
15	NULL
)	NULL
and	NULL
expressed	NULL
as	NULL
percentage	NULL
of	NULL
acetylated	NULL
chloramphenicol	NULL
.	NULL

Intraexperi-ment	NULL
variations	NULL
were	NULL
controlled	NULL
by	NULL
cotransfection	NULL
of	NULL
the	NULL
pSV	NULL
control	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
by	NULL
determining	NULL
the	NULL
protein	NULL
concentration	NULL
of	NULL
cell	NULL
extracts	NULL
.	NULL

For	NULL
each	NULL
construct	NULL
,	NULL
independent	NULL
transfections	NULL
were	NULL
performed	NULL
at	NULL
least	NULL
twice	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
and	NULL
D	NULL
,	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
as	NULL
described	NULL
(	NULL
15	NULL
)	NULL
,	NULL
with	NULL
0-5	NULL
ug	NULL
of	NULL
c-Ets-1	NULL
or	NULL
c-Ets-2	NULL
expression	NULL
vectors	NULL
(	NULL
21	NULL
)	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
RSV-f	NULL
&	NULL
-galactosidase	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
CD4-based	NULL
or	NULL
SV40	NULL
CAT	NULL
plasmids	NULL
.	NULL

CAT	NULL
activities	NULL
are	NULL
expressed	NULL
as	NULL
cpm	NULL
of	NULL
monoacetylated	NULL
[	NULL
'*CJchloramphenicol	NULL
corrected	NULL
for	NULL
variations	NULL
of	NULL
the	NULL
A-galactosidase	NULL
internal	NULL
control	NULL
.	NULL

For	NULL
each	NULL
construct	NULL
,	NULL
three	NULL
experiments	NULL
with	NULL
at	NULL
least	NULL
two	NULL
preparations	NULL
of	NULL
DNA	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
difference	NULL
between	NULL
individual	NULL
experiments	NULL
was	NULL
no	NULL
more	NULL
than	NULL
20	NULL
%	NULL
.	NULL

Stable	NULL
transformants	NULL
of	NULL
CEM	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
cotransfection	NULL
with	NULL
a	NULL
plasmid	NULL
encoding	NULL
the	NULL
hygromycin	NULL
B	NULL
phosphotransferase	NULL
gene	NULL
.	NULL

Electrophoretic-Mobility-Shift	NULL
Assays	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Similar	NULL
titers	NULL
of	NULL
octamer-binding	NULL
factors	NULL
were	NULL
recovered	NULL
from	NULL
CEM	NULL
and	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
.	NULL

Electrophoretic-mobility-shift	NULL
assays	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
23	NULL
)	NULL
:	NULL
Nuclear	NULL
extract	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
20	NULL
ul	NULL
of	NULL
binding	NULL
buffer	NULL
containing	NULL
0.5-1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
-poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
the	NULL
appropriate	NULL
competitor	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Then	NULL
,	NULL
1	NULL
ng	NULL
of	NULL
P-labeled	NULL
probe	NULL
was	NULL
added	NULL
for	NULL
a	NULL
further	NULL
20-min	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Nucleoprotein	NULL
complexes	NULL
were	NULL
resolved	NULL
in	NULL
a	NULL
6	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

RESULTS	NULL
Localization	NULL
of	NULL
the	NULL
CD4	NULL
Transcription	NULL
Start	NULL
Site	NULL
.	NULL

We	NULL
used	NULL
the	NULL
5	NULL
Hinfl	NULL
fragment	NULL
(	NULL
nt	NULL
+12	NULL
to	NULL
+198	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
of	NULL
a	NULL
human	NULL
CD4	NULL
cDNA	NULL
(	NULL
cDNA	NULL
?	NULL
)	NULL

112	NULL
bp	NULL
longer	NULL
upstream	NULL
than	NULL
the	NULL
first	NULL
described	NULL
human	NULL
cDNA	NULL
(	NULL
cDNA1	NULL
)	NULL
(	NULL
5	NULL
)	NULL
to	NULL
probe	NULL
AMP	NULL
,	NULL
the	NULL
most	NULL
5	NULL
'	NULL
human	NULL
CD4	NULL
genomic	NULL
clone	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Restriction	NULL
mapping	NULL
and	NULL
sequencing	NULL
of	NULL
the	NULL
hybridizing	NULL
fragments	NULL
identified	NULL
a	NULL
large	NULL
9.6-kb	NULL
intron	NULL
in	NULL
the	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Human	NULL
and	NULL
murine	NULL
CD4	NULL
genes	NULL
have	NULL
thus	NULL
a	NULL
similar	NULL
organization	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Primer	NULL
extension	NULL
of	NULL
CD4	NULL
mRNAs	NULL
revealed	NULL
a	NULL
major	NULL
transcript	NULL
starting	NULL
at	NULL
an	NULL
adenine	NULL
(	NULL
+1	NULL
in	NULL
all	NULL
figures	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
and	NULL
minor	NULL
transcripts	NULL
starting	NULL
at	NULL
nt	NULL
-9	NULL
,	NULL
-1	NULL
,	NULL
+2	NULL
,	NULL
and	NULL
+5	NULL
.	NULL

Mung	NULL
bean	NULL
nuclease	NULL
mapping	NULL
gave	NULL
protected	NULL
fragments	NULL
corresponding	NULL
to	NULL
5	NULL
'	NULL
ends	NULL
located	NULL
between	NULL
nt	NULL
+1	NULL
and	NULL
+5	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
with	NULL
a	NULL
major	NULL
protected	NULL
fragment	NULL
corresponding	NULL
to	NULL
nt	NULL
+3	NULL
.	NULL

This	NULL
apparent	NULL
discrepancy	NULL
,	NULL
also	NULL
observed	NULL
under	NULL
various	NULL
stringency	NULL
conditions	NULL
,	NULL
is	NULL
presumably	NULL
due	NULL
to	NULL
an	NULL
overdigestion	NULL
of	NULL
the	NULL
A+T-rich	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
RNA-DNA	NULL
duplexes	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Start	NULL
sites	NULL
are	NULL
identical	NULL
in	NULL
lymphoid	NULL
(	NULL
CEM	NULL
)	NULL
and	NULL
monocytic	NULL
(	NULL
U937	NULL
)	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
murine	NULL
CD4	NULL
gene	NULL
(	NULL
16	NULL
)	NULL
.	NULL

A	NULL
minimal	NULL
human	NULL
CD4	NULL
gene	NULL
core	NULL
promoter	NULL
(	NULL
nt	NULL
-40	NULL
to	NULL
+16	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
SV40	NULL
enhancer	NULL
and	NULL
CAT	NULL
gene	NULL
(	NULL
construct	NULL
pT4+eSV	NULL
)	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
stable	NULL
transformants	NULL
of	NULL
CEM	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

Primer-extension	NULL
analysis	NULL
of	NULL
Biochemistry	NULL
:	NULL
Salmon	NULL
et	NULL
al	NULL
.	NULL

x	NULL
*0030\	NULL
?	NULL

°Q's\°	NULL
@	NULL
®	NULL
T	NULL
G	NULL
C	NULL
A	NULL
P	NULL
&	NULL
&	NULL
in	NULL
i	NULL
I	NULL
|	NULL
t	NULL
AGCACGAATTTACTTCTCTCTGTCCTT	NULL
AGCACGAATTTACTTCTCTCTGTCCTTCGG	NULL
e	NULL
m	NULL
+	NULL
a	NULL
N	NULL
/	NULL
+1	NULL
7	NULL
4	NULL
+9	NULL
-	NULL
%	NULL
40	NULL
_	NULL
TCTCTTCATTTAAGCA	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Identification	NULL
of	NULL
human	NULL
CD4	NULL
mRNA	NULL
5	NULL
'	NULL
end	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Primer-extension	NULL
analysis	NULL
.	NULL

Total	NULL
RNAs	NULL
from	NULL
yeast	NULL
,	NULL
HeLa	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
CEM	NULL
cells	NULL
were	NULL
analyzed	NULL
using	NULL
an	NULL
oligonucleotide	NULL
complementary	NULL
to	NULL
nt	NULL
+35	NULL
to	NULL
+74	NULL
of	NULL
human	NULL
CD4	NULL
mRNA	NULL
as	NULL
primer	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
mRNA	NULL
's	NULL
5	NULL
'	NULL
ends	NULL
beside	NULL
the	NULL
sequence	NULL
of	NULL
nt	NULL
-18	NULL
to	NULL
+12	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
coding	NULL
strand	NULL
.	NULL

Position	NULL
+1	NULL
corresponds	NULL
to	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Mung	NULL
bean	NULL
nuclease	NULL
analysis	NULL
.	NULL

Total	NULL
RNAs	NULL
from	NULL
yeast	NULL
and	NULL
U937	NULL
and	NULL
CEM	NULL
cells	NULL
were	NULL
analyzed	NULL
using	NULL
an	NULL
oligonucleotide	NULL
complementary	NULL
to	NULL
nt	NULL
-31	NULL
to	NULL
+44	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
.	NULL

Arrow	NULL
40	NULL
indicates	NULL
the	NULL
migration	NULL
position	NULL
of	NULL
a	NULL
40-base	NULL
oligonucleotide	NULL
.	NULL

Thick	NULL
bar	NULL
,	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
major	NULL
protected	NULL
fragment	NULL
;	NULL
thin	NULL
bars	NULL
,	NULL
5	NULL
ends	NULL
of	NULL
the	NULL
minor	NULL
protected	NULL
fragments	NULL
.	NULL

They	NULL
are	NULL
aligned	NULL
with	NULL
nt	NULL
-7	NULL
to	NULL
+9	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
coding	NULL
strand	NULL
.	NULL

Position	NULL
+1	NULL
designates	NULL
the	NULL
major	NULL
start	NULL
site	NULL
identified	NULL
by	NULL
primer-extension	NULL
analysis	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Transcription	NULL
initiation	NULL
from	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
.	NULL

Stable	NULL
transformants	NULL
of	NULL
the	NULL
CD4*	NULL
cell	NULL
lines	NULL
CEM	NULL
(	NULL
clone	NULL
3B3	NULL
)	NULL
and	NULL
Jurkat	NULL
(	NULL
clone	NULL
A5	NULL
)	NULL
,	NULL
expressing	NULL
the	NULL
CAT	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
pT4+eSV	NULL
construct	NULL
were	NULL
analyzed	NULL
by	NULL
primer	NULL
extension	NULL
.	NULL

An	NULL
oligonucleotide	NULL
complementary	NULL
to	NULL
nt	NULL
+3	NULL
to	NULL
+42	NULL
of	NULL
the	NULL
CAT	NULL
mRNA	NULL
(	NULL
+1	NULL
being	NULL
the	NULL
first	NULL
nucleotide	NULL
of	NULL
the	NULL
CAT	NULL
initiation	NULL
codon	NULL
)	NULL
was	NULL
used	NULL
as	NULL
primer	NULL
.	NULL

The	NULL
major	NULL
start	NULL
site	NULL
of	NULL
CAT	NULL
mRNAs	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
(	NULL
nt	NULL
+1	NULL
)	NULL
,	NULL
beside	NULL
nt	NULL
-15	NULL
to	NULL
+12	NULL
of	NULL
the	NULL
coding	NULL
strand	NULL
.	NULL

CAT	NULL
mRNAs	NULL
showed	NULL
that	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
CAT	NULL
transcripts	NULL
start	NULL
at	NULL
the	NULL
+1	NULL
adenine	NULL
of	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Structural	NULL
Analysis	NULL
of	NULL
the	NULL
Human	NULL
CD4	NULL
Gene	NULL
Promoter	NULL
.	NULL

Despite	NULL
precise	NULL
initiation	NULL
,	NULL
there	NULL
are	NULL
no	NULL
consensus	NULL
sequences	NULL
such	NULL
as	NULL
TATA	NULL
box	NULL
(	NULL
6	NULL
)	NULL
,	NULL
CAAT	NULL
box	NULL
(	NULL
25	NULL
)	NULL
,	NULL
or	NULL
initiator	NULL
(	NULL
7	NULL
)	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

We	NULL
identified	NULL
three	NULL
ETS	NULL
(	NULL
8	NULL
)	NULL
and	NULL
seven	NULL
MYB	NULL
(	NULL
26	NULL
)	NULL
consensus	NULL
sequences	NULL
in	NULL
the	NULL
CD4	NULL
promoter	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
six	NULL
MYB	NULL
consensus	NULL
sequences	NULL
described	NULL
in	NULL
the	NULL
murine	NULL
CD4	NULL
promoter	NULL
(	NULL
16	NULL
)	NULL
,	NULL
only	NULL
two	NULL
are	NULL
found	NULL
in	NULL
the	NULL
corresponding	NULL
human	NULL
region	NULL
.	NULL

We	NULL
found	NULL
a	NULL
significant	NULL
conservation	NULL
(	NULL
64	NULL
%	NULL
)	NULL
between	NULL
human	NULL
and	NULL
mouse	NULL
proximal	NULL
promoter	NULL
sequences	NULL
(	NULL
nt	NULL
-163	NULL
to	NULL
+20	NULL
;	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
which	NULL
is	NULL
concentrated	NULL
in	NULL
five	NULL
boxes	NULL
of	NULL
100	NULL
%	NULL
homology	NULL
.	NULL

Three	NULL
of	NULL
these	NULL
conserved	NULL
boxes	NULL
(	NULL
CB1-3	NULL
)	NULL
are	NULL
located	NULL
in	NULL
the	NULL
region	NULL
from	NULL
positions	NULL
-35	NULL
to	NULL
+15	NULL
,	NULL
which	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
RNA	NULL
polymerase	NULL
complex	NULL
(	NULL
RPC	NULL
)	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

CBI	NULL
and	NULL
-3	NULL
are	NULL
in	NULL
places	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
(	NULL
nt	NULL
-35	NULL
to	NULL
-27	NULL
)	NULL
(	NULL
6	NULL
)	NULL
and	NULL
initiator	NULL
(	NULL
nt	NULL
-3	NULL
to	NULL
+5	NULL
)	NULL
(	NULL
7	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
CB2	NULL
sequence	NULL
(	NULL
nt	NULL
-18	NULL
to	NULL
-7	NULL
)	NULL
is	NULL
precisely	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
of	NULL
Ets-1	NULL
[	NULL
RC	NULL
(	NULL
C/A	NULL
)	NULL
GGA	NULL
(	NULL
A/T	NULL
)	NULL
RY	NULL
,	NULL
minus	NULL
strand	NULL
,	NULL
where	NULL
R	NULL
is	NULL
a	NULL
purine	NULL
and	NULL
Y	NULL
is	NULL
a	NULL
pyrimidine	NULL
]	NULL
,	NULL
whereas	NULL
the	NULL
remote	NULL
ETS	NULL
sequence	NULL
(	NULL
nt	NULL
-1065	NULL
to	NULL
-1057	NULL
)	NULL
is	NULL
perfect	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
E74-related	NULL
proteins	NULL
[	NULL
YC	NULL
(	NULL
C/A	NULL
)	NULL
GGAART	NULL
,	NULL
minus	NULL
strand	NULL
]	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
7741	NULL
CD4	NULL
Promoter	NULL
and	NULL
Core	NULL
Promoter	NULL
Tissue	NULL
Specificity	NULL
and	NULL
Transactivation	NULL
by	NULL
Ets	NULL
.	NULL

Compared	NULL
to	NULL
the	NULL
ubiquitously	NULL
active	NULL
SV40	NULL
promoter	NULL
,	NULL
the	NULL
CD4	NULL
promoter	NULL
is	NULL
tissue-specific	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Its	NULL
activity	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
SV40	NULL
promoter	NULL
in	NULL
a	NULL
mature	NULL
CD4+*	NULL
T-cell	NULL
line	NULL
(	NULL
Jurkat	NULL
)	NULL
,	NULL
4-fold	NULL
lower	NULL
in	NULL
CD4t	NULL
monocytic	NULL
cells	NULL
(	NULL
U937	NULL
)	NULL
,	NULL
and	NULL
a	NULL
least	NULL
10-fold	NULL
lower	NULL
in	NULL
CD4~	NULL
cells	NULL
,	NULL
including	NULL
the	NULL
RPMI	NULL
pre-T	NULL
cells	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
proT4	NULL
is	NULL
also	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
SV40	NULL
in	NULL
an	NULL
immature	NULL
CD4*/	NULL
CD8+*	NULL
T-cell	NULL
line	NULL
(	NULL
CEM	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
(	NULL
nt	NULL
-40	NULL
to	NULL
+16	NULL
)	NULL
alone	NULL
exhibits	NULL
a	NULL
significant	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
the	NULL
presence	NULL
of	NULL
positive	NULL
regulatory	NULL
sequences	NULL
both	NULL
upstream	NULL
and	NULL
within	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
.	NULL

When	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
is	NULL
coupled	NULL
to	NULL
the	NULL
SV40	NULL
enhancer	NULL
(	NULL
pT4+eSV	NULL
)	NULL
,	NULL
its	NULL
transcriptional	NULL
activity	NULL
is	NULL
similar	NULL
in	NULL
CD4*	NULL
and	NULL
CD4~	NULL
cells	NULL
and	NULL
is	NULL
in	NULL
the	NULL
same	NULL
order	NULL
of	NULL
magnitude	NULL
as	NULL
the	NULL
SV40	NULL
promoter	NULL
.	NULL

In	NULL
CD4~	NULL
Hela	NULL
cells	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
CD4	NULL
promoter	NULL
and	NULL
core	NULL
promoter	NULL
can	NULL
be	NULL
restored	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
.	NULL

The	NULL
CD4	NULL
core	NULL
promoter	NULL
alone	NULL
(	NULL
pT4	NULL
)	NULL
and	NULL
to	NULL
a	NULL
greater	NULL
extent	NULL
the	NULL
complete	NULL
CD4	NULL
promoter	NULL
(	NULL
proT4	NULL
)	NULL
are	NULL
transactivated	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
by	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

These	NULL
Ets	NULL
proteins	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
SV	NULL
40	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
both	NULL
CD4	NULL
core	NULL
promoter	NULL
and	NULL
upstream	NULL
sequences	NULL
are	NULL
targets	NULL
for	NULL
activation	NULL
by	NULL
Ets	NULL
proteins	NULL
.	NULL

Binding	NULL
of	NULL
Ets-Like	NULL
Proteins	NULL
to	NULL
the	NULL
Human	NULL
CD4	NULL
Core	NULL
Promoter	NULL
.	NULL

We	NULL
performed	NULL
gel-retardation	NULL
assays	NULL
with	NULL
both	NULL
the	NULL
56-bp	NULL
CD4	NULL
core	NULL
promoter	NULL
sequence	NULL
and	NULL
a	NULL
sequence	NULL
containing	NULL
an	NULL
artificial	NULL
ETS	NULL
motif	NULL
derived	NULL
from	NULL
the	NULL
described	NULL
consensus	NULL
sequence	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
a	NULL
labeled	NULL
CD4	NULL
probe	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
CD4*	NULL
CEM	NULL
cells	NULL
gave	NULL
three	NULL
retarded	NULL
bands	NULL
(	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
;	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Preincubation	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
CD4	NULL
,	NULL
as	NULL
well	NULL
as	NULL
unlabeled	NULL
ETS	NULL
motifs	NULL
,	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
most	NULL
intense	NULL
C3	NULL
band	NULL
,	NULL
although	NULL
with	NULL
a	NULL
lesser	NULL
efficiency	NULL
for	NULL
ETS	NULL
.	NULL

These	NULL
different	NULL
affinities	NULL
of	NULL
CD4	NULL
and	NULL
ETS	NULL
for	NULL
the	NULL
C3	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
are	NULL
most	NULL
likely	NULL
due	NULL
to	NULL
base	NULL
differences	NULL
between	NULL
their	NULL
Ets-binding	NULL
sites	NULL
(	NULL
21	NULL
,	NULL
29	NULL
)	NULL
.	NULL

No	NULL
significant	NULL
inhibition	NULL
was	NULL
observed	NULL
when	NULL
using	NULL
as	NULL
competitors	NULL
an	NULL
altered	NULL
ETS	NULL
motif	NULL
with	NULL
a	NULL
single	NULL
C	NULL
-	NULL
T	NULL
substitution	NULL
(	NULL
MUT	NULL
)	NULL
or	NULL
a	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
oligonucleotide	NULL
(	NULL
pA	NULL
)	NULL
.	NULL

By	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
CD4~	NULL
HeLa	NULL
cells	NULL
,	NULL
the	NULL
C1	NULL
and	NULL
C2	NULL
bands	NULL
displayed	NULL
intensities	NULL
comparable	NULL
to	NULL
bands	NULL
of	NULL
CEM	NULL
extracts	NULL
,	NULL
whereas	NULL
the	NULL
C3	NULL
band	NULL
was	NULL
almost	NULL
undetectable	NULL
.	NULL

Furthermore	NULL
,	NULL
only	NULL
the	NULL
C3	NULL
band	NULL
could	NULL
be	NULL
significantly	NULL
inhibited	NULL
by	NULL
the	NULL
CD4	NULL
unlabeled	NULL
competitor	NULL
.	NULL

Using	NULL
the	NULL
ETS	NULL
double-strand	NULL
oligonucleotide	NULL
as	NULL
probe	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
similar	NULL
pattern	NULL
of	NULL
retarded	NULL
bands	NULL
.	NULL

Three	NULL
bands	NULL
(	NULL
El	NULL
,	NULL
E2	NULL
,	NULL
and	NULL
E3	NULL
)	NULL
were	NULL
observed	NULL
with	NULL
nuclear	NULL
extracts	NULL
of	NULL
CEM	NULL
cells	NULL
,	NULL
whereas	NULL
only	NULL
two	NULL
(	NULL
E1	NULL
and	NULL
E2	NULL
)	NULL
were	NULL
found	NULL
with	NULL
HeLa	NULL
cells	NULL
.	NULL

An	NULL
excess	NULL
of	NULL
unlabeled	NULL
ETS	NULL
oligonucleotide	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
E3	NULL
,	NULL
although	NULL
less	NULL
efficiently	NULL
than	NULL
the	NULL
CD4	NULL
oligonucleotide	NULL
.	NULL

No	NULL
significant	NULL
inhibition	NULL
was	NULL
observed	NULL
with	NULL
MUT	NULL
or	NULL
the	NULL
pA	NULL
oligonucleotides	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Structure	NULL
and	NULL
Tissue	NULL
Specificity	NULL
of	NULL
the	NULL
Human	NULL
CD4	NULL
Promoter	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
the	NULL
transcription	NULL
initiation	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
is	NULL
precise	NULL
and	NULL
that	NULL
a	NULL
genomic	NULL
fragment	NULL
from	NULL
nt	NULL
-1076	NULL
to	NULL
+20	NULL
governs	NULL
tissue-specific	NULL
transcriptional	NULL
activity	NULL
in	NULL
CD4+*	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
those	NULL
recently	NULL
reported	NULL
(	NULL
16	NULL
)	NULL
for	NULL
a	NULL
murine	NULL
CD4	NULL
gene	NULL
promoter	NULL
fragment	NULL
of	NULL
similar	NULL
size	NULL
whose	NULL
activity	NULL
is	NULL
restricted	NULL
to	NULL
mature	NULL
CD4*/	NULL
CD8~	NULL
mouse	NULL
lymphocytes	NULL
.	NULL

Within	NULL
the	NULL
1100-bp	NULL
human	NULL
fragment	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
region	NULL
from	NULL
positions	NULL
-40	NULL
to	NULL
+16	NULL
can	NULL
direct	NULL
precise	NULL
transcription	NULL
at	NULL
the	NULL
same	NULL
site	NULL
as	NULL
natural	NULL
CD4	NULL
mRNAs	NULL
and	NULL
displays	NULL
a	NULL
significant	NULL
tissue-specific	NULL
basal	NULL
activity	NULL
.	NULL

This	NULL
latter	NULL
feature	NULL
is	NULL
unusual	NULL
for	NULL
a	NULL
minimal	NULL
core	NULL
promoter	NULL
,	NULL
although	NULL
sequences	NULL
of	NULL
similar	NULL
size	NULL
have	NULL
been	NULL
7742	NULL
Biochemistry	NULL
:	NULL
Salmon	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
A	NULL
B	NULL
112	NULL
24	NULL
7	NULL
H	NULL
HeLa	NULL
2	NULL
a	NULL
1	NULL
Jurkat	NULL
3	NULL
>	NULL
0.8	NULL
8	NULL
8	NULL
j	NULL
9	NULL
SV40	NULL
g	NULL
0	NULL
7	NULL
§	NULL
17	NULL
$	NULL
0	NULL
,	NULL
car	NULL
)	NULL
(	NULL
at	NULL
)	NULL
O.4-_	NULL
o	NULL
-	NULL
o	NULL
Jurkat	NULL
-	NULL
U937	NULL
-	NULL
RPMI	NULL
HeLa	NULL
-	NULL
Astro	NULL
HepG2	NULL
Basic	NULL
proTA4	NULL
pT4	NULL
-	NULL
pT4+eSV	NULL
-	NULL
sv40	NULL
7	NULL
84	NULL
-	NULL
Plasmid	NULL
Ets-1	NULL
,	NULL
ug	NULL
«	NULL
84	NULL
-	NULL
Plasmid	NULL
Ets-2	NULL
,	NULL
ug	NULL
o	NULL
&	NULL
m	NULL
-	NULL
1	NULL
[	NULL
am	NULL
Fol	NULL
+	NULL
C	NULL
0	NULL
X	NULL
64	NULL
Bi	NULL
x	NULL
64	NULL
1	NULL
g	NULL
m	NULL
5	NULL
3	NULL
]	NULL
I	NULL
5	NULL
o	NULL
E	NULL
4	NULL
4	NULL
g	NULL
4	NULL
$	NULL
S	NULL
g	NULL
2-1	NULL
g	NULL
2	NULL
-o-	NULL
-H	NULL
0	NULL
#	NULL
pT4	NULL
proT4	NULL
SV40	NULL
pT4	NULL
proTA4	NULL
SsV40	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
CD4	NULL
promoter	NULL
and	NULL
core	NULL
promoter	NULL
are	NULL
tissue-specific	NULL
and	NULL
are	NULL
activated	NULL
by	NULL
Ets	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cell-specific	NULL
expression	NULL
of	NULL
the	NULL
CD4	NULL
promoter	NULL
.	NULL

CD4	NULL
+	NULL
(	NULL
Jurkat	NULL
and	NULL
U937	NULL
)	NULL
and	NULL
CD4~	NULL
(	NULL
RPMI	NULL
,	NULL
Hela	NULL
,	NULL
Astro	NULL
,	NULL
and	NULL
HepG2	NULL
)	NULL
cell	NULL
lines	NULL
were	NULL
electroporated	NULL
with	NULL
SV40	NULL
and	NULL
proT4	NULL
plasmids	NULL
in	NULL
a	NULL
pUC19	NULL
parental	NULL
plasmid	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
determined	NULL
as	NULL
percentages	NULL
of	NULL
acetylated	NULL
vs.	NULL
total	NULL
chloramphenicol	NULL
,	NULL
and	NULL
proT4	NULL
activity	NULL
was	NULL
expressed	NULL
as	NULL
its	NULL
relative	NULL
value	NULL
to	NULL
SV40	NULL
activity	NULL
.	NULL

Means	NULL
(	NULL
bars	NULL
)	NULL
and	NULL
standard	NULL
deviations	NULL
to	NULL
the	NULL
mean	NULL
(	NULL
error	NULL
bars	NULL
)	NULL
of	NULL
these	NULL
relative	NULL
activities	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
horizontal	NULL
line	NULL
shows	NULL
the	NULL
SV40	NULL
relative	NULL
activity	NULL
(	NULL
index	NULL
=	NULL
1	NULL
)	NULL
.	NULL

Average	NULL
absolute	NULL
activities	NULL
(	NULL
chloramphenicol	NULL
acetylation	NULL
percentage	NULL
per	NULL
hour	NULL
)	NULL
for	NULL
the	NULL
SV40	NULL
promoter	NULL
(	NULL
and	NULL
Basic	NULL
)	NULL
constructs	NULL
were	NULL
=~24	NULL
(	NULL
1.8	NULL
)	NULL
for	NULL
Jurkat	NULL
,	NULL
27	NULL
(	NULL
0.15	NULL
)	NULL
for	NULL
U937	NULL
,	NULL
80	NULL
(	NULL
0.4	NULL
)	NULL
for	NULL
RPMI	NULL
,	NULL
140	NULL
(	NULL
0.15	NULL
)	NULL
for	NULL
HeLa	NULL
,	NULL
83	NULL
(	NULL
0.25	NULL
)	NULL
for	NULL
Astro	NULL
,	NULL
and	NULL
41	NULL
(	NULL
0.3	NULL
)	NULL
for	NULL
HepG2	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transcriptional	NULL
activities	NULL
of	NULL
the	NULL
CD4	NULL
promoter	NULL
and	NULL
core	NULL
promoter	NULL
in	NULL
HeLa	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

Basic	NULL
,	NULL
proT4	NULL
,	NULL
pT4	NULL
,	NULL
and	NULL
pT4+eSV	NULL
were	NULL
tested	NULL
in	NULL
the	NULL
Bluescript	NULL
parental	NULL
plasmid	NULL
.	NULL

Activities	NULL
of	NULL
each	NULL
construct	NULL
,	NULL
determined	NULL
as	NULL
in	NULL
A	NULL
,	NULL
were	NULL
related	NULL
to	NULL
SV40	NULL
promoter	NULL
activity	NULL
(	NULL
index	NULL
=	NULL
1	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
(	NULL
bars	NULL
)	NULL
and	NULL
standard	NULL
deviations	NULL
to	NULL
the	NULL
mean	NULL
(	NULL
error	NULL
bars	NULL
)	NULL
of	NULL
these	NULL
relative	NULL
activities	NULL
.	NULL

Average	NULL
absolute	NULL
activities	NULL
(	NULL
chloramphenicol	NULL
acetylation	NULL
percentage	NULL
per	NULL
hour	NULL
)	NULL
for	NULL
the	NULL
SV40	NULL
promoter	NULL
were	NULL
~80	NULL
for	NULL
Jurkat	NULL
and	NULL
50	NULL
for	NULL
HeLa	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Transactivation	NULL
of	NULL
CD4	NULL
promoter	NULL
and	NULL
core	NULL
promoter	NULL
by	NULL
Ets-1	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pT4	NULL
,	NULL
proT4	NULL
,	NULL
or	NULL
SV40	NULL
;	NULL
5	NULL
ug	NULL
of	NULL
RSV-B-galactosidase	NULL
vector	NULL
;	NULL
and	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
a	NULL
c-Ets-1	NULL
expression	NULL
vector	NULL
.	NULL

CAT	NULL
activities	NULL
are	NULL
expressed	NULL
as	NULL
corrected	NULL
cpm	NULL
.	NULL

Results	NULL
of	NULL
a	NULL
representative	NULL
experiment	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Transactivation	NULL
of	NULL
CD4	NULL
promoter	NULL
and	NULL
core	NULL
promoter	NULL
by	NULL
Ets-2	NULL
.	NULL

Same	NULL
as	NULL
C	NULL
but	NULL
with	NULL
an	NULL
c-Ets-2	NULL
expression	NULL
vector	NULL
.	NULL

Experiments	NULL
of	NULL
C	NULL
and	NULL
D	NULL
were	NULL
performed	NULL
with	NULL
plasmids	NULL
based	NULL
on	NULL
the	NULL
pUC19	NULL
parental	NULL
plasmid	NULL
.	NULL

shown	NULL
to	NULL
participate	NULL
in	NULL
tissue-specific	NULL
transcription	NULL
in	NULL
vitro	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
human	NULL
CD4	NULL
core	NULL
promoter	NULL
contains	NULL
three	NULL
boxes	NULL
(	NULL
CB1-3	NULL
)	NULL
,	NULL
which	NULL
are	NULL
identical	NULL
in	NULL
mouse	NULL
CD4	NULL
gene	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
CBI	NULL
and	NULL
CB3	NULL
suggest	NULL
that	NULL
they	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
RPC	NULL
assembly	NULL
,	NULL
although	NULL
they	NULL
do	NULL
not	NULL
correspond	NULL
to	NULL
the	NULL
consensus	NULL
reported	NULL
at	NULL
these	NULL
sites	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
TATA	NULL
box	NULL
(	NULL
6	NULL
)	NULL
,	NULL
initiator	NULL
(	NULL
CTCANTCT	NULL
)	NULL
(	NULL
7	NULL
)	NULL
,	NULL
or	NULL
HIPI	NULL
(	NULL
ATTTCN:1-3	NULL
,	NULL
GCCA	NULL
)	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
second	NULL
CB	NULL
(	NULL
CB2	NULL
)	NULL
contains	NULL
a	NULL
perfect	NULL
sequence	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
Ets-1	NULL
protein	NULL
(	NULL
29	NULL
)	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
the	NULL
CD4	NULL
A	NULL
CD4	NULL
5-	NULL
AGCTTGTGTGGAGGAGCCTITGCCATCGGGCT	NULL
TCCTGTCTCTCTTCAT	NULL
T	NULL
TAAGCACGACTCT	NULL
-3	NULL
'	NULL
ACACACCTCCTCGGAACGGTAGCCCGAAGGACAGAGAGAAGTAAATTCGTGCTGAGAGATC	NULL
ETS	NULL
5-	NULL
TTTTGTTTGAGACCTTCAACTTCCTCACCCCAGCCATGTG	NULL
-	NULL
3°	NULL
CAAACTCTGGAAGTITGAAGGAGTGGGGTCGGTACACTTTT	NULL
MUT	NULL
5-	NULL
TTTTGTTTGAGACCTTCAA	NULL
a	NULL
ACCCCAGCCATGTG	NULL
-	NULL
3	NULL
'	NULL
CAAACTCTGGAAG	NULL
GA	NULL
GGGTCGGTACACTTTT	NULL
pA	NULL
5'-	NULL
AGCTAAAATAAAGCGCCAAATAAAGCGCCAAATAAAGCGCCAAGCTTGCATGCCTGCAGGTCGACT	NULL
-3	NULL
'	NULL
TTTTATTTCGCGGTTTATTTCGCGGTTTATTTCGCGGTTCGAACGTACGGACGTCCAGCTGAGATC	NULL
B|	NULL
Cell	NULL
CEM	NULL
HeLa	NULL
competitor	NULL
ETS	NULL
__	NULL
MUT	NULL
___	NULL
CD4	NULL
pA	NULL
ETS	NULL
MUT	NULL
CD4	NULL
pA	NULL
30	NULL
300|	NULL
30	NULL
300|	NULL
30	NULL
300|30	NULL
300	NULL
0	NULL
|	NULL
so	NULL
|	NULL
30	NULL
|	NULL
30	NULL
|	NULL
30	NULL
C3	NULL
-	NULL
»	NULL
2	NULL
-	NULL
»	NULL
1	NULL
-	NULL
»	NULL
F_	NULL
--	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

-	NULL
CD4	NULL
core	NULL
promoter	NULL
binds	NULL
an	NULL
Ets-related	NULL
protein	NULL
present	NULL
in	NULL
CD4+*	NULL
but	NULL
not	NULL
in	NULL
CD4~	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Sequences	NULL
of	NULL
the	NULL
double-strand	NULL
oligonucleotides	NULL
used	NULL
for	NULL
the	NULL
electrophoretic-mobility-shift	NULL
assays	NULL
.	NULL

CD4	NULL
is	NULL
the	NULL
oligonucleotide	NULL
also	NULL
used	NULL
in	NULL
the	NULL
CAT	NULL
constructs	NULL
.	NULL

ETS	NULL
contains	NULL
an	NULL
artificial	NULL
Ets-binding	NULL
site	NULL
designed	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
reported	NULL
consensus	NULL
_	NULL
sequence	NULL
(	NULL
8	NULL
)	NULL
inserted	NULL
in	NULL
a	NULL
nonrelevant	NULL
sequence	NULL
.	NULL

MUT	NULL
is	NULL
identical	NULL
to	NULL
ETS	NULL
except	NULL
for	NULL
the	NULL
detrimental	NULL
G	NULL
-	NULL
A	NULL
mutation	NULL
(	NULL
21	NULL
)	NULL
(	NULL
minus	NULL
strand	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
pA	NULL
was	NULL
used	NULL
as	NULL
negative	NULL
control	NULL
.	NULL

CD4	NULL
core	NULL
promoter	NULL
conserved	NULL
sequences	NULL
and	NULL
Ets-binding	NULL
core	NULL
sequences	NULL
are	NULL
boxed	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Electrophoretic-mobility	NULL
shifts	NULL
of	NULL
CD4	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
CEM	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

Competitors	NULL
used	NULL
are	NULL
indicated	NULL
above	NULL
their	NULL
respective	NULL
molar	NULL
excess	NULL
to	NULL
the	NULL
CD4	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Lane	NULL
0	NULL
means	NULL
no	NULL
competitor	NULL
added	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
free	NULL
probe	NULL
(	NULL
F	NULL
)	NULL
and	NULL
of	NULL
the	NULL
retarded	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
)	NULL
.	NULL

Biochemistry	NULL
:	NULL
Salmon	NULL
et	NULL
al	NULL
.	NULL

core	NULL
promoter	NULL
specifically	NULL
binds	NULL
an	NULL
Ets	NULL
protein	NULL
present	NULL
at	NULL
high	NULL
amounts	NULL
specifically	NULL
in	NULL
CD4*	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
activate	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
in	NULL
the	NULL
CD4~-	NULL
HeLa	NULL
cells	NULL
,	NULL
and	NULL
preliminary	NULL
experiments	NULL
indicated	NULL
that	NULL
mutations	NULL
within	NULL
CB2	NULL
dramatically	NULL
impairs	NULL
activation	NULL
by	NULL
Ets	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
strongly	NULL
suggests	NULL
that	NULL
Ets	NULL
proteins	NULL
are	NULL
implicated	NULL
in	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
in	NULL
CD4*	NULL
cells	NULL
,	NULL
by	NULL
activating	NULL
the	NULL
RPC	NULL
from	NULL
within	NULL
.	NULL

As	NULL
recently	NULL
discussed	NULL
for	NULL
other	NULL
TATA-less	NULL
promoters	NULL
,	NULL
Ets	NULL
proteins	NULL
could	NULL
participate	NULL
in	NULL
the	NULL
building	NULL
of	NULL
a	NULL
CD4-specific	NULL
RPC	NULL
(	NULL
8	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Independently	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
complete	NULL
CD4	NULL
promoter	NULL
is	NULL
more	NULL
active	NULL
in	NULL
CD4*	NULL
cells	NULL
and	NULL
more	NULL
strongly	NULL
activated	NULL
by	NULL
Ets	NULL
in	NULL
CD4~	NULL
cells	NULL
than	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
Ets	NULL
proteins	NULL
could	NULL
also	NULL
``	NULL
classically	NULL
``	NULL
modulate	NULL
CD4	NULL
gene	NULL
expression	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
other	NULL
remote	NULL
upstream	NULL
ETS	NULL
site	NULL
(	NULL
nt	NULL
-1060	NULL
)	NULL
.	NULL

Ets	NULL
proteins	NULL
,	NULL
whose	NULL
prototype	NULL
is	NULL
the	NULL
Ets-/	NULL
protooncogene	NULL
,	NULL
define	NULL
a	NULL
distinct	NULL
class	NULL
of	NULL
transcriptional	NULL
factors	NULL
that	NULL
bind	NULL
several	NULL
gene	NULL
regulatory	NULL
sequences	NULL
containing	NULL
the	NULL
ETS	NULL
core	NULL
motif	NULL
GGA	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
ref	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Among	NULL
these	NULL
proteins	NULL
,	NULL
Ets-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
control	NULL
a	NULL
T-cell-specific	NULL
gene	NULL
(	NULL
TCRa	NULL
)	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
Elf-1	NULL
is	NULL
implicated	NULL
in	NULL
a	NULL
T-helper-cell-specific	NULL
gene	NULL
expression	NULL
(	NULL
interleukin	NULL
2	NULL
)	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
distal	NULL
ETS	NULL
site	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
preferred	NULL
by	NULL
Elf-1-related	NULL
proteins	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
cooperation	NULL
of	NULL
these	NULL
two	NULL
proteins	NULL
could	NULL
be	NULL
a	NULL
key	NULL
mechanism	NULL
for	NULL
CD4	NULL
gene	NULL
restricted	NULL
expression	NULL
.	NULL

Ets-1	NULL
and	NULL
Ets-2	NULL
are	NULL
expressed	NULL
at	NULL
10-fold	NULL
higher	NULL
levels	NULL
in	NULL
CD4+*	NULL
thymocytes	NULL
and	NULL
lymphocytes	NULL
than	NULL
in	NULL
their	NULL
CD8+	NULL
counterparts	NULL
(	NULL
11	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
are	NULL
expressed	NULL
at	NULL
low	NULL
but	NULL
significant	NULL
levels	NULL
in	NULL
CD8*	NULL
lympho-cytes	NULL
,	NULL
whereas	NULL
the	NULL
CD4	NULL
gene	NULL
expression	NULL
is	NULL
undetectable	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

These	NULL
apparent	NULL
discrepancies	NULL
might	NULL
be	NULL
explained	NULL
by	NULL
(	NULL
i	NULL
)	NULL
the	NULL
fact	NULL
that	NULL
Ets	NULL
is	NULL
not	NULL
the	NULL
sole	NULL
determinant	NULL
of	NULL
CD4	NULL
promoter	NULL
activity	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
a	NULL
threshold	NULL
effect	NULL
of	NULL
Ets	NULL
expression	NULL
on	NULL
CD4	NULL
promoter	NULL
activity	NULL
,	NULL
or	NULL
(	NULL
ii	NULL
?	NULL
)	NULL

the	NULL
presence	NULL
of	NULL
interfering	NULL
forms	NULL
of	NULL
Ets	NULL
in	NULL
CD4~	NULL
cells	NULL
.	NULL

For	NULL
optimal	NULL
activity	NULL
,	NULL
Ets	NULL
proteins	NULL
seem	NULL
to	NULL
require	NULL
the	NULL
adjacent	NULL
binding	NULL
of	NULL
another	NULL
transcriptional	NULL
factor	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
ref	NULL
.	NULL

8	NULL
)	NULL
,	NULL
including	NULL
Myb	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
Myb	NULL
is	NULL
also	NULL
critical	NULL
for	NULL
CD4	NULL
promoter	NULL
activity	NULL
(	NULL
16	NULL
)	NULL
,	NULL
although	NULL
it	NULL
does	NULL
not	NULL
by	NULL
itself	NULL
significantly	NULL
contribute	NULL
to	NULL
its	NULL
tissue	NULL
specificity	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
tissue-specific	NULL
CD4	NULL
promoter	NULL
activity	NULL
could	NULL
depend	NULL
on	NULL
the	NULL
cooperation	NULL
of	NULL
Ets	NULL
proteins	NULL
,	NULL
with	NULL
Myb	NULL
at	NULL
the	NULL
distal	NULL
ETS-MYB	NULL
overlapping	NULL
sites	NULL
,	NULL
or	NULL
with	NULL
a	NULL
general	NULL
transcription	NULL
factor	NULL
at	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
ETS	NULL
site	NULL
.	NULL

Finally	NULL
,	NULL
preliminary	NULL
experiments	NULL
indicated	NULL
that	NULL
truncated	NULL
forms	NULL
of	NULL
Ets	NULL
containing	NULL
only	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
34	NULL
)	NULL
dramatically	NULL
decrease	NULL
CD4	NULL
promoter	NULL
activity	NULL
in	NULL
CD4	NULL
#	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
results	NULL
clearly	NULL
indicate	NULL
that	NULL
Ets	NULL
proteins	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
tissue-restricted	NULL
CD4	NULL
gene	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
the	NULL
CD4-specific	NULL
Ets	NULL
proteins	NULL
remain	NULL
to	NULL
be	NULL
identified	NULL
.	NULL

The	NULL
CD4	NULL
Promoter	NULL
and	NULL
Thymocyte	NULL
Phenotype	NULL
Switching	NULL
.	NULL

Experiments	NULL
with	NULL
transgenic	NULL
mice	NULL
suggested	NULL
that	NULL
the	NULL
CD4	NULL
and	NULL
CD8	NULL
proteins	NULL
could	NULL
control	NULL
their	NULL
mutual	NULL
expression	NULL
during	NULL
thymocyte	NULL
diffentiation	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Such	NULL
events	NULL
could	NULL
likely	NULL
be	NULL
triggered	NULL
by	NULL
p56	NULL
``	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
v-src	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
family	NULL
that	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
intracyto-plasmic	NULL
tails	NULL
of	NULL
these	NULL
proteins	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
(	NULL
i	NULL
)	NULL
p56	NULL
``	NULL
phos-phorylates	NULL
and	NULL
activates	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinases	NULL
(	NULL
36	NULL
)	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
Ets	NULL
phosphorylation	NULL
by	NULL
MAP	NULL
kinase	NULL
modifies	NULL
its	NULL
ability	NULL
to	NULL
form	NULL
ternary	NULL
complex	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
37	NULL
)	NULL
,	NULL
and	NULL
(	NULL
ii	NULL
?	NULL
)	NULL

v-src	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
modulate	NULL
Ets	NULL
transcriptional	NULL
activity	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Ets	NULL
could	NULL
be	NULL
the	NULL
nuclear	NULL
target	NULL
of	NULL
extracellular	NULL
signals	NULL
that	NULL
might	NULL
trigger	NULL
thymocyte	NULL
phenotype	NULL
switch	NULL
.	NULL

We	NULL
thank	NULL
M.	NULL
Dowling	NULL
for	NULL
his	NULL
participation	NULL
to	NULL
preliminary	NULL
experiments	NULL
and	NULL
R.	NULL
Axel	NULL
for	NULL
providing	NULL
the	NULL
AMP	NULL
CD4	NULL
genomic	NULL
clone	NULL
and	NULL
constant	NULL
support	NULL
for	NULL
this	NULL
project	NULL
.	NULL

This	NULL
work	NULL
was	NULL
funded	NULL
by	NULL
grants	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
7743	NULL
from	NULL
Association	NULL
National	NULL
pour	NULL
la	NULL
Recherche	NULL
du	NULL
SIDA	NULL
,	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
,	NULL
Direction	NULL
de	NULL
la	NULL
Recherche	NULL
et	NULL
des	NULL
Etudes	NULL
Doctorales	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
contre	NULL
le	NULL
Can-cer	NULL
,	NULL
and	NULL
Federation	NULL
Nationale	NULL
des	NULL
Centres	NULL
de	NULL
Lutte	NULL
Contre	NULL
le	NULL
Cancer	NULL
.	NULL

Nikolic-Zugic	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
12	NULL
,	NULL
65-70	NULL
.	NULL

Robey	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Fowlkes	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Gordon	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Kioussis	NULL
,	NULL
D.	NULL
,	NULL
von	NULL
Bochmer	NULL
,	NULL
H.	NULL
,	NULL
Ramsdell	NULL
,	NULL
F.	NULL
&	NULL
Axel	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
99-107	NULL
.	NULL

Seong	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Chamberlain	NULL
,	NULL
J.	NULL
W.	NULL
&	NULL
Parnes	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
356	NULL
,	NULL
718-720	NULL
.	NULL

Littman	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Thomas	NULL
,	NULL
Y.	NULL
,	NULL
Maddon	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Chess	NULL
,	NULL
L.	NULL
&	NULL
Axel	NULL
,	NULL
R.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
40	NULL
,	NULL
237-246	NULL
.	NULL

Maddon	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Littman	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Godfrey	NULL
,	NULL
M.	NULL
,	NULL
Maddon	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Chess	NULL
,	NULL
L.	NULL
&	NULL
Axel	NULL
,	NULL
R.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
42	NULL
,	NULL
93-104	NULL
.	NULL

Breathnach	NULL
,	NULL
R.	NULL
&	NULL
Chambon	NULL
,	NULL
P.	NULL
(	NULL
1981	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

50	NULL
,	NULL
349-383	NULL
.	NULL

Smale	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Schmidt	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Berk	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
4509-4513	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
Hahn	NULL
,	NULL
S.	NULL
L.	NULL
&	NULL
Giovane	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

211	NULL
,	NULL
7-18	NULL
.	NULL

Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
Gottschalk	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Lindsten	NULL
,	NULL
T.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Papas	NULL
,	NULL
T.	NULL
S.	NULL
&	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
250	NULL
,	NULL
814-818	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Wang	NULL
,	NULL
C.	NULL
,	NULL
Ho	NULL
,	NULL
I.	NULL
,	NULL
Bohjanen	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Petryniak	NULL
,	NULL
B.	NULL
,	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Miesfeldt	NULL
,	NULL
S.	NULL
,	NULL
Zhang	NULL
,	NULL
L.	NULL
,	NULL
Nabel	NULL
,	NULL
G.	NULL
H.	NULL
,	NULL
Karpinski	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
1043-1053	NULL
.	NULL

Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
Komschlies	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Fujiwara	NULL
,	NULL
S.	NULL
,	NULL
Fisher	NULL
,	NULL
R.J.	NULL
,	NULL
Mathieson	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Gregorio	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Young	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Kasik	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Ozato	NULL
,	NULL
K.	NULL
&	NULL
Papas	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
672-678	NULL
.	NULL

12	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
McKercher	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Celada	NULL
,	NULL
A.	NULL
,	NULL
Beveren	NULL
,	NULL
C.	NULL
V.	NULL
&	NULL
Maki	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
113-124	NULL
.	NULL

13	NULL
.	NULL

Ben-David	NULL
,	NULL
Y.	NULL
,	NULL
Giddens	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
Letwin	NULL
,	NULL
K.	NULL
&	NULL
Bernstein	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
908-918	NULL
.	NULL

14	NULL
.	NULL

LaMarco	NULL
,	NULL
K.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Byers	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Walton	NULL
,	NULL
E.	NULL
M.	NULL
&	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
253	NULL
,	NULL
789-792	NULL
.	NULL

15	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

Press	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

16	NULL
.	NULL

Siu	NULL
,	NULL
G.	NULL
,	NULL
Wurster	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Lipsick	NULL
,	NULL
J.	NULL
S.	NULL
&	NULL
Hedrick	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
1592-1604	NULL
.	NULL

17	NULL
.	NULL

Gorman	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Tourvieille	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Parnes	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
7644-7648	NULL
.	NULL

18	NULL
.	NULL

Tourvieille	NULL
,	NULL
B.	NULL
,	NULL
Gorman	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Field	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Hunkapilier	NULL
,	NULL
T.	NULL
&	NULL
Parnes	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
234	NULL
,	NULL
610-614	NULL
.	NULL

19	NULL
.	NULL

Littman	NULL
,	NULL
D.	NULL
R.	NULL
&	NULL
Gettner	NULL
,	NULL
S.	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
325	NULL
,	NULL
453-455	NULL
.	NULL

20	NULL
.	NULL

Salmon	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Ph.D.	NULL
thesis	NULL
(	NULL
Pierre	NULL
and	NULL
Marie	NULL
Curie	NULL
Univ	NULL
.	NULL

,	NULL
Paris	NULL
)	NULL
.	NULL

21	NULL
.	NULL

Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
Gutman	NULL
,	NULL
A.	NULL
,	NULL
Nicholson	NULL
,	NULL
R.	NULL
&	NULL
Wasylyk	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1127-1134	NULL
.	NULL

22	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Miiller	NULL
,	NULL
M.	NULL
M.	NULL
&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
.	NULL

23	NULL
.	NULL

Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
Flores	NULL
,	NULL
P.	NULL
,	NULL
Gutman	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Wasylyk	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
3371-3378	NULL
.	NULL

24	NULL
.	NULL

Maddon	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Molineaux	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Maddon	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Zimmerman	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Godfrey	NULL
,	NULL
M.	NULL
,	NULL
Alt	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Chess	NULL
,	NULL
L.	NULL
&	NULL
Axel	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
9155-9159	NULL
.	NULL

25	NULL
.	NULL

McKnight	NULL
,	NULL
S.	NULL
L.	NULL
&	NULL
Kingsbury	NULL
,	NULL
R.	NULL
(	NULL
1982	NULL
)	NULL
Science	NULL
217	NULL
,	NULL
316-324	NULL
.	NULL

26	NULL
.	NULL

Biedenkapp	NULL
,	NULL
H.	NULL
,	NULL
Borgmeyer	NULL
,	NULL
U.	NULL
,	NULL
Sippel	NULL
,	NULL
A.	NULL
E.	NULL
&	NULL
Klempnauer	NULL
,	NULL
K.-H.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
335	NULL
,	NULL
835-837	NULL
.	NULL

27.	NULL
van	NULL
Dyke	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
&	NULL
Sawadogo	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
1335-1338	NULL
.	NULL

28	NULL
.	NULL

Buratowski	NULL
,	NULL
S.	NULL
,	NULL
Hahn	NULL
,	NULL
S.	NULL
,	NULL
Guarente	NULL
,	NULL
L.	NULL
&	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
56	NULL
,	NULL
549-561	NULL
.	NULL

29	NULL
.	NULL

Nye	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Petersen	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Gunther	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Jonsen	NULL
,	NULL
M.	NULL
D.	NULL
&	NULL
Graves	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
975-990	NULL
.	NULL

30	NULL
.	NULL

Tamura	NULL
,	NULL
T.	NULL
,	NULL
Sumita	NULL
,	NULL
K.	NULL
,	NULL
Hirose	NULL
,	NULL
S.	NULL
&	NULL
Mikoshiba	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
3101-3108	NULL
.	NULL

31	NULL
.	NULL

Means	NULL
,	NULL
A.	NULL
L.	NULL
&	NULL
Farnham	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
653-661	NULL
.	NULL

32	NULL
.	NULL

Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
819-821	NULL
.	NULL

33	NULL
.	NULL

Dudek	NULL
,	NULL
H.	NULL
,	NULL
Tantravahi	NULL
,	NULL
R.	NULL
V.	NULL
,	NULL
Rao	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
Reddy	NULL
,	NULL
E.	NULL
S.	NULL
&	NULL
Reddy	NULL
,	NULL
E.	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
1291-1295	NULL
.	NULL

34	NULL
.	NULL

Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
Kerckaert	NULL
,	NULL
J.-P.	NULL
&	NULL
Wasylyk	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
965-974	NULL
.	NULL

35	NULL
.	NULL

Veillette	NULL
,	NULL
A.	NULL
,	NULL
Bookman	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Horak	NULL
,	NULL
E.	NULL
M.	NULL
&	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
301-308	NULL
.	NULL

36	NULL
.	NULL

Ettahadich	NULL
,	NULL
E.	NULL
,	NULL
Sanghera	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Pelech	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Hess-Bienz	NULL
,	NULL
D.	NULL
,	NULL
Watts	NULL
,	NULL
J.	NULL
,	NULL
Shastri	NULL
,	NULL
N.	NULL
&	NULL
Aebersold	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
255	NULL
,	NULL
853-855	NULL
.	NULL

37	NULL
.	NULL

Gille	NULL
,	NULL
H.	NULL
,	NULL
Sharrocks	NULL
,	NULL
A.	NULL
D.	NULL
&	NULL
Shaw	NULL
,	NULL
P.	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
358	NULL
,	NULL
414-417.	NULL
o	NULL
®	NULL
nog	NULL
jo	NULL
oom	NULL
yo	NULL
Np	NULL
tea	NULL
®	NULL
ja	NULL

